Apella - About the company
Apella is a series B company based in San Francisco (United States), founded in 2021 by Jordan Tuttle and Cameron Marlow. It operates as a Developer of surgical systems for the operating room. Apella has raised $101M in funding from Casdin Capital and HighlandX. The company has 222 active competitors, including 74 funded and 15 that have exited. Its top competitors include companies like ClearPoint Neuro, LensAR and Onkos Surgical.
Company Details
Developer of surgical systems for the operating room. The products of the company include sensors for operating rooms that harness artificial intelligence approaches to collect and analyze new data about surgery. It has applications targeted at improving hospital operations, surgical quality, staff training, and real-time decision-making.
- Website
- apella.io
- Email ID
- *****@apella.io
Key Metrics
Founded Year
2021
Location
San Francisco, United States
Stage
Series B
Total Funding
$101M in 2 rounds
Latest Funding Round
Investors
Ranked
5th among 222 active competitors
Employee Count
132 as on Sep 30, 2026
Similar Companies
Legal entities associated with Apella
Apella is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
APELLA TECHNOLOGIES INC CIN: 843625528 , United States, Active | Dec 31, 1999 | - | 67 (As on Dec 31, 2024) | - |
APELLA TECHNOLOGY INC. CIN: 84-3625528 , United States, Active | Oct 03, 2019 | - | 14 (As on Dec 31, 2021) | - |
Sign up to download Apella's company profile
Apella's funding and investors
Apella has raised a total funding of $101M over 2 rounds. Its first funding round was on Dec 20, 2021. Its latest funding round was a Series B round on Jan 08, 2026 for $*****. 8 investors participated in its latest round. Apella has 10 institutional investors.
Here is the list of recent funding rounds of Apella:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 08, 2026 | 6284489 | Series B | 5250847 | 3726618 | 8710639 | 2998984 |
Dec 20, 2021 | 2865327 | Series A | 9018360 | 8839995 |
View details of Apella's funding rounds and investors
Apella's founders and board of directors
Founder? Claim ProfileThe founders of Apella are Jordan Tuttle and Cameron Marlow.
Here are the details of Apella's key team members:
- Jordan Tuttle: Co-Founder of Apella. Contact Info: 1 email address
- Cameron Marlow: Co-Founder & CTO of Apella. Contact Info: 1 email address
View details of Apella's Founder profiles and Board Members
Apella's employee count trend
Apella has 132 employees as of Sep 26. Here is Apella's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Apella's Competitors and alternates
Top competitors of Apella include ClearPoint Neuro, LensAR and Onkos Surgical. Here is the list of Top 10 competitors of Apella, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ClearPoint Neuro 1998, Irvine (United States), Public | Developer of MRI-guided stereotactic system for neurological interventions | $33.7M | 66/100 | |
2nd | LensAR 2004, Orlando (United States), Acquired | Laser Technology with AR feature for cataract surgery | $99M | 64/100 | |
3rd | Onkos Surgical 2015, Parsippany Troy Hills (United States), Series C | Modular segmental solutions (3D printing) for orthopedic procedures | $110M | 63/100 | |
4th | Proprio 2016, Seattle (United States), Series B | Manufacturer of surgical navigation platforms using artificial intelligence and sensors | $74.2M | 63/100 | |
5th | Apella 2021, San Francisco (United States), Series B | Developer of surgical systems for the operating room | $101M | 65/100 | |
6th | Hypervision Surgical 2020, London (United Kingdom), Series A | AI-based tissue analysis software for surgical precision | $31M | 60/100 | |
7th | VitVio 2023, San Francisco (United States), Seed | AI and computer vision platform for surgical operating rooms | $10M | 60/100 | |
8th | MediView 2017, Cleveland (United States), Series A | Developer of augmented reality visualization systems for medical surgical procedures | $92.8M | 58/100 | |
9th | Caranx Medical 2020, Paris (France), Acquired | Provide of innovative surgical robotics | - | - | 57/100 |
10th | Provider of web-based software platform for perioperative care to surgical clinics | $4.88M | 55/100 |
Looking for more details on Apella's competitors? Click here to see the top ones
Apella's Investments and acquisitions
Apella has made no investments or acquisitions yet.
Reports related to Apella
Here is the latest report on Apella's sector:
News related to Apella
Media has covered Apella for 1 event in last 1 year.
•
Apella Secures $80M to Scale Ambient Video Intelligence Across Surgical SuiteHIT Consultant•Jan 08, 2026•Apella, Vensana Capital, K2 HealthVentures, Houston Methodist and 5 others
•
Apella Announces $21 Million Series A Funding to Digitize the Operating RoomBusiness Wire•Dec 20, 2021•Apella, Casdin Capital, Vensana Capital, Twine Ventures and 3 others
Are you a Founder ?
FAQs about Apella
Explore our recently published companies
- Finques Dorca - Cabrils based, 1999 founded, Unfunded company
- Goupilix - France based, 2025 founded, Unfunded company
- DualSOFT - Unfunded company
- Finexerp - Bahrain based, Unfunded company
- EDEXA ACADEMY - Hayes based, 2024 founded, Unfunded company
- Group512 - Austin based, 2023 founded, Unfunded company
